Share chart Centogene N.V.
Extended chart
Simple chart
About
Centogene N.V., together with its subsidiaries, engages in the research and development of products for human genetics in Europe, the Middle East, North America, Latin America, and the Asia Pacific. It provides data-driven answers to patients, physicians, and pharmaceutical companies for rare and neurodegenerative diseases. It operates through two segments: Pharmaceutical and Diagnostics. The company provides target and drug screening, clinical development, market access and expansion, as well as CENTOGENE Biodatabank licenses and insight report services. more details| EBITDA | -0.0045 |
|---|---|
| EV/EBITDA | -2.32 |
| IPO date | 2019-11-07 |
| ISIN | NL0014040206 |
| Industry | Health Care Providers & Services |
| P/BV | 2.69 |
| P/S | 3.25 |
| Sector | Health Care |
| Валюта | usd |
| Валюта отчета | eur |
| Выручка | 0.0405 |
| Сайт | https://www.centogene.com |
| Цена ао | 0.2238 |
| Число акций ао | 0.02681 млрд |
| Change price per day: | 0% (0.1211) |
|---|---|
| Change price per week: | -9.9% (0.1344) |
| Change price per month: | +34.56% (0.09) |
| Change price per 3 month: | -39.45% (0.2) |
| Change price per half year: | -70.32% (0.408) |
| Change price per year: | -89.91% (1.2) |
| Change price per 3 year: | -97.66% (5.17) |
| Change price per 5 year: | -99.07% (13.05) |
| Change price per 10 year: | 0% (0.1211) |
| Change price per year to date: | 0% (0.1211) |
|
|
Underestimation
|
Efficiency
|
|||||||||||||||||||||||||||||||||||||
Dividends
|
Debt
|
Growth impulse
|
|||||||||||||||||||||||||||||||||||||
| Institutions | Volume | Share, % |
|---|---|---|
| Platinum Investment Management Ltd | 2377150 | 8.61 |
| Wells Fargo & Company | 206389 | 0.75 |
| Acadian Asset Management. LLC | 24703 | 0.09 |
| Blackrock Inc. | 21578 | 0.08 |
| Millennium Management LLC | 19731 | 0.07 |
| Morgan Stanley | 18231 | 0.07 |
| Stifel Financial Corporation | 16450 | 0.06 |
| Barclays PLC | 15348 | 0.06 |
| Geode Capital Management, LLC | 11156 | 0.04 |
| Meeder Asset Management, Inc. | 138 | 0 |
| Head | Job title | Payment | Year of birth |
|---|---|---|---|
| Ms. Kim Stratton | CEO & Member of Management Board | 932.62k | 1962 (63 years) |
| Mr. Jose Miguel Coego Rios | CFO, Legal & IT and Member of Management Board | 323.87k | 1974 (51 year) |
| Dr. Peter Bauer M.D. | Interim MD, Chief Medical & Genomic Officer and Member of Management Board | 186.31k | 1970 (55 years) |
| Dr. Andrin Oswald M.D., Ph.D. | Advisor | 943.45k | 1972 (53 years) |
| Mr. Ian Rentsch | Chief Commercial Officer & GM of Pharma | N/A | 1976 (49 years) |
Address: Germany, Rostock, Am Strande 7 - open in Google maps, open in Yandex maps
Website: https://www.centogene.com
Website: https://www.centogene.com
